Aspen Grove Capital, LLC Astrazeneca PLC Transaction History
Aspen Grove Capital, LLC
- $472 Billion
- Q4 2024
A detailed history of Aspen Grove Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aspen Grove Capital, LLC holds 3,360 shares of AZN stock, worth $261,945. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,360
Previous 6,277
46.47%
Holding current value
$261,945
Previous $489 Million
54.98%
% of portfolio
0.05%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...